DuPont Showcases Leading Battery Pack Solutions at the 16th Chongqing International Battery Technology Exhibition

With the recent rise of Cell-to-Pack (CTP) technology, battery cells are directly integrated into battery packs—eliminating module frames and reducing the total number of components. This significantly improves pack efficiency and energy density. Higher energy density extends driving range, while fewer components enable cost optimization and lightweighting. BETAFORCE™ TC polyurethane thermally conductive structural adhesives offer thermal conductivity, enabling structural bonding between cells and cooling plates for uniform thermal management—enhancing driving safety and performance. This product also supports fast charging by bonding active cooling units to cells or modules. Additionally, to enhance structural integrity, extend battery pack service life, and improve crash resistance, the showcased battery pack solutions include: BETAMATE™ structural adhesives for battery bonding; BETAFORCE™ composite adhesives; and BETAFILL™ foam and potting solutions. To ensure safer and more efficient operation under high-voltage and rapid-charging conditions, DuPont will also introduce Kapton® polyimide films—offering enhanced electrical insulation alongside superior thermal conductivity. DuPont–Fuchs Memorandum of Cooperation Signing Ceremony (Left to right: Feng Qian, New Energy Market Development Manager, Asia Pacific, DuPont Adhesives; Ting Luo, Market Manager, Asia Pacific, DuPont Adhesives; Qiang Xing, Global Market Director, DuPont Adhesives; Shu Wang, Vice President, China Immersion Market, Fuchs; Qinjian Zhou, Senior Industry Manager, Immersion Market, Fuchs; Yong Pang, General Manager, APAC, Böddeker & Mühl) On the first day of the exhibition, DuPont signed a Memorandum of Cooperation with Fuchs Group, committing to jointly deliver high-quality technologies, products, and services to customers in the energy storage and new-energy vehicle industries. “With China’s new-energy industry experiencing rapid growth, the energy storage market is witnessing unprecedented opportunities. DuPont aims to strengthen collaboration with Fuchs to seize these opportunities, leverage our respective expertise, and—guided by sustainability principles—create greater value for energy storage customers and the broader supply chain,” said Qiang Xing, Global Market Director of DuPont Adhesives and Brake Fluids. Regarding the MoU signing during the battery exhibition, Mr. Shu Wang, Vice President of Fuchs’ China Immersion Market, commented: “As a critical component of China’s energy reform, the energy storage industry plays a pivotal role across all energy sectors. With rapid industry expansion, energy storage system technologies continue to evolve. Fuchs looks forward to partnering with DuPont—a company possessing formidable technical capabilities—to promote advanced technologies and deliver products to Chinese users that are safer, more efficient, more reliable, and longer-lasting—thereby advancing energy reform and accelerating progress toward carbon neutrality.” About DuPont DuPont (NYSE: DD) delivers science-based materials, ingredients, and solutions—driving innovation across industries and enriching everyday life worldwide.

DuPont™ Liveo™ to Exhibit at Medtec China 2026, Advancing Healthcare Development Through Localization Strategy and Product Innovation

Localization is merely one step along our continuous innovation journey. As the medical device industry advances toward higher performance, longer service life, and stricter safety standards, advanced materials innovation has become a key driver of industry progress. Recently, DuPont™ Liveo™ pharmaceutical-grade ultra-low-temperature TPE tubing received the 2026 R&D 100 Award—the world’s most prestigious award recognizing groundbreaking technological innovations. This honor underscores DuPont’s leadership in biopharmaceutical process materials innovation. Specifically engineered for ultra-low-temperature biopharmaceutical applications, this tubing maintains exceptional flexibility and performance stability under extreme cold—helping customers overcome critical challenges in biopharmaceutical manufacturing, storage, and transportation. At this year’s Medtec China, DuPont™ Liveo™ unveiled two innovative products tailored for long-term implantable and skin-contact medical device applications. The Liveo™ Q7-88XX series of liquid silicone rubber (LSR) is designed specifically for long-term implantation (>29 days), offering outstanding biocompatibility, mechanical properties, and long-term stability—meeting the stringent reliability and durability requirements of implantable devices. For example, it supports the exploration, development, and commercialization of implantable neuromodulation systems and medical-grade brain-computer interfaces—providing device manufacturers with a trusted material solution. Meanwhile, Liveo™ MG-2543 silicone elastomer—featuring high transparency, low viscosity, excellent processability, and compliance with relevant medical biocompatibility testing—offers greater design flexibility and process adaptability for medical device encapsulation, microneedle mold fabrication, IVD test consumables, medical PCB protection, LED phototherapy device encapsulation, precision molding, and innovative device design—accelerating product development and bringing innovations to market faster. These newly launched products further enrich DuPont™ Liveo™’s portfolio of high-performance healthcare materials—demonstrating the company’s steadfast commitment to advancing materials innovation and meeting the industry’s ever-evolving demands. Leveraging deep insights into medical device safety, reliability, and long-term performance, DuPont™ Liveo™ is dedicated to delivering higher-value material solutions that empower next-generation medical product innovation and development. At the new product launch event, Dean Childers, Vice President and General Manager of DuPont Healthcare Solutions, stated: “China is one of the world’s most dynamic and innovative markets for healthcare and life sciences. In response to rapidly escalating market demands, DuPont™ Liveo™ continues to advance its localization strategy—strengthening local supply and service capabilities to respond more swiftly to customer needs. Simultaneously, we are intensifying investment in innovation—leveraging cutting-edge materials science and application development expertise to launch novel products and solutions aligned with future medical applications.” From deepening localization to continuously driving product innovation, DuPont™ Liveo™ consistently places customer needs and industry trends at the core—actively enhancing local supply and service capabilities while continually expanding its portfolio of healthcare-focused materials.

DuPont de Nemours (NYSE:DD) Now Covered by Analysts at Barclays

3 days ago

Barclays initiated coverage on DuPont de Nemours with an overweight rating and $156 price target, following quarterly earnings that exceeded expectations with $1.88 EPS.

MarketBeat

2026-04-09

Oak Thistle LLC Acquires 46,908 Shares in DuPont de Nemours Inc.

2026-04-09

Oak Thistle LLC Acquires 46,908 Shares in DuPont de Nemours

2026-04-13

BMO Capital Markets Raises DuPont de Nemours Price Target to $60

2026-04-15

DuPont de Nemours Maintains Quarterly Dividend at $0.20 Per Share

2026-04-16

Robeco Institutional Asset Management B.V. Decreases Stake in DuPont de Nemours, Inc.